How Participants Perceive Biomedical Research in Pulmonology (PROTOACCEPT2)

University Hospital Center (CHU)

Status: Completed

Conditions: Biomedical Research

Treatments: Other: Questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT03397056

RECHMPL17_0447

Details and patient eligibility

About

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Full description

Over time, clinical research has become a challenge both in terms of public health and in terms of scientific progress. Additionally, it has also become a financial challenge for institutions, especially in France where a significant part of their government funding is provided according to their ability to conduct quality clinical research. Pulmonology is a sector where clinical research is well established with strong incentives from several pharmaceutical companies and numerous academic research projects. Nevertheless, it is important to put the patient back at the centre of biomedical research.

A better knowledge of patient expectations, questions and misunderstandings would considerably improve treatment observance, clinical trial data quality, doctor-patient trust/relationship, and ultimately, the patient's health.

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

The secondary objectives are to determine:

• how biomedical research is experienced / felt;
• if the information delivered to the patient (orally - information note) is clearly perceived.

Comparisons with PROTOACCEPT1 (osf.io/nsjjr) will also be performed.

Enrollment: 500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient presents with at least one of the following: (1) asthma, (2) chronic obstructive pulmonary disease, (3) bronchiectasis, (4) idiopathic pulmonary fibrosis, (5) pulmonary arterial hypertension, (6) sleep apnoea syndrome
• The patient is participating in a biomedical research protocol.

Exclusion criteria

• Patient under 18 years of age
• Patient judged incapable of filling out the questionnaire for linguistic or other reasons.
• The patient has already participated in the present study.

Trial design

500 participants in 1 patient group

The study population

Description:

The target population corresponds to patients with a respiratory disease already included in a biomedical research protocol. Intervention: Questionnaire

Treatment:

Other: Questionnaire